Herbert Irving Comprehensive Cancer Center (Columbia University)
Columbia University Medical Center
New York, NY
Filters
Save & Share
Clear Filters
Diagnosis
Treatment History
Classifications
Explore trials based on treatment classification/type.
Targets
Explore trials based on treatment targets.
MSK Service
Filter trials based on MSK Service
Accepting patients
CA088-1005
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component
Learn more- CAR T Cell
- CELMoD
- GPRC5D
- Phase 1
- Myeloma Service